# Solesence, Inc.: overview SLSN · Nasdaq · CIK 883107 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/slsn.md) · [Financials](/companies/slsn/financials.md) · [Filings](/companies/slsn/filings.md) · [Insiders](/companies/slsn/insiders.md) Latest reported revenue: [$15.3m](/filings/0001999371-26-018231.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 19, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001999371-26-018231). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [16.9](/filings/0001999371-25-017415.md) | [12.6 d](/filings/0001999371-26-007345.md) | [14.6](/filings/0001999371-26-010555.md) | [20.4](/filings/0001999371-26-018231.md) | [14.6](/filings/0001999371-25-017415.md) | [12.5 d](/filings/0001999371-26-007345.md) | [13.0](/filings/0001999371-26-010555.md) | [15.3](/filings/0001999371-26-018231.md) | | Gross margin | % | [36.2%](/filings/0001999371-25-017415.md) | [22.0% d](/filings/0001999371-26-007345.md) | [23.1%](/filings/0001999371-26-010555.md) | [31.6%](/filings/0001999371-26-018231.md) | [23.1%](/filings/0001999371-25-017415.md) | [27.5% d](/filings/0001999371-26-007345.md) | [24.2%](/filings/0001999371-26-018231.md) | [31.0%](/filings/0001999371-26-018231.md) | | Operating margin | % | [19.0%](/filings/0001999371-25-017415.md) | [(1.8%) d](/filings/0001999371-26-007345.md) | [1.8%](/filings/0001999371-26-010555.md) | [12.2%](/filings/0001999371-26-018231.md) | [(5.4%)](/filings/0001999371-25-017415.md) | [1.5% d](/filings/0001999371-26-007345.md) | [(5.4%)](/filings/0001999371-26-018231.md) | [0.8%](/filings/0001999371-26-018231.md) | | Net margin | % | [18.1%](/filings/0001999371-25-017415.md) | [(4.4%) d](/filings/0001999371-26-007345.md) | [2.3%](/filings/0001999371-26-018231.md) | [15.9%](/filings/0001999371-26-018231.md) | [(7.7%)](/filings/0001999371-25-017415.md) | [1.3% d](/filings/0001999371-26-007345.md) | [(7.4%)](/filings/0001999371-26-018231.md) | [(1.0%)](/filings/0001999371-26-018231.md) | | Diluted EPS | $ per share | [0.04](/filings/0001999371-25-017415.md) | not reported | [0.00](/filings/0001999371-26-010555.md) | [0.04](/filings/0001999371-26-018231.md) | [(0.02)](/filings/0001999371-25-017415.md) | not reported | [(0.01)](/filings/0001999371-26-018231.md) | [0.00](/filings/0001999371-26-018231.md) | | Free cash flow | $m | [2.8 d](/filings/0001999371-25-017415.md) | [(0.4) d](/filings/0001999371-26-007345.md) | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [29.5](/filings/0001839882-23-007887.md) | [37.3](/filings/0001999371-24-004138.md) | [37.3](/filings/0001999371-25-003471.md) | [52.3](/filings/0001999371-26-007345.md) | [62.1](/filings/0001999371-26-007345.md) | | Gross margin | % | [29.5%](/filings/0001839882-23-007887.md) | [22.4%](/filings/0001999371-24-004138.md) | [21.0%](/filings/0001999371-25-003471.md) | [30.9%](/filings/0001999371-26-007345.md) | [25.9%](/filings/0001999371-26-007345.md) | | Operating margin | % | [8.7%](/filings/0001839882-23-007887.md) | [(6.1%)](/filings/0001999371-24-004138.md) | [(9.5%)](/filings/0001999371-25-003471.md) | [9.8%](/filings/0001999371-26-007345.md) | [2.5%](/filings/0001999371-26-007345.md) | | Net margin | % | [7.9%](/filings/0001839882-23-007887.md) | [(7.0%)](/filings/0001999371-24-004138.md) | [(11.8%)](/filings/0001999371-25-003471.md) | [8.1%](/filings/0001999371-26-007345.md) | [2.9%](/filings/0001999371-26-007345.md) | | Diluted EPS | $ per share | [0.05](/filings/0001839882-23-007887.md) | [(0.05)](/filings/0001999371-24-004138.md) | [(0.09)](/filings/0001999371-25-003471.md) | [0.07](/filings/0001999371-26-007345.md) | [0.02](/filings/0001999371-26-007345.md) | | Free cash flow | $m | [0.4](/filings/0001839882-23-007887.md) | [(4.5)](/filings/0001999371-24-004138.md) | [(3.1)](/filings/0001999371-25-003471.md) | [(2.6)](/filings/0001999371-26-007345.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/slsn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $610.4k | 830,508 | | Added +18,797 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $340.8k | 463,652 | | Reduced −605,097 | | [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $233.4k | 317,609 | | Added +273,536 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $203.2k | 276,497 | | New +276,497 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $175.4k | 238,514 | | Reduced −213,015 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $138.8k | 188,797 | | Reduced −5,985 | | [DONALDSON CAPITAL MANAGEMENT, LLC](/funds/1487438.md) | 2026-06-30 | $110.3k | 150,000 | | New +150,000 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $81.8k | 111,340 | | Added +97,382 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $78.4k | 106,692 | | Reduced −16,314 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $73.0k | 99,385 | | New +99,385 | ## Recent filings [All 769 filings](/companies/slsn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-05 | 20:55 ET | [8-K](/filings/0001171843-26-006412.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001171843-26-006412 | | 2026-10-02 | 20:00 ET | [8-K](/filings/0001171843-26-006367.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001171843-26-006367 | | 2026-08-21 | 16:30 ET | [8-K](/filings/0001171843-26-005702.md) | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001171843-26-005702 | | 2026-08-20 | 16:12 ET | [8-K](/filings/0001171843-26-005676.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005676 | | 2026-08-19 | 21:03 ET | [10-Q](/filings/0001999371-26-018231.md) | Quarterly report, period 2026-06-30 | 0001999371-26-018231 | | 2026-07-10 | 21:00 ET | [8-K](/filings/0001171843-26-004582.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001171843-26-004582 | | 2026-05-12 | 20:19 ET | [10-Q](/filings/0001999371-26-010555.md) | Quarterly report, period 2026-03-31 | 0001999371-26-010555 | | 2026-05-12 | 12:15 ET | [8-K](/filings/0001171843-26-003273.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003273 | | 2026-04-29 | 12:00 ET | [8-K](/filings/0001171843-26-002802.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-26-002802 | | 2026-04-23 | 20:13 ET | [10-K/A](/filings/0001999371-26-008861.md) | Annual report, amended, period 2025-12-31 | 0001999371-26-008861 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001999371-26-007345.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b1b5e7f1-d465-4548-abf9-ba3302b38875) ## About the filer - CIK: 883107 - Tickers: SLSN - Exchange: Nasdaq - SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.